Cargando…
Patient-Derived Ex Vivo Cultures and Endpoint Assays with Surrogate Biomarkers in Functional Testing for Prediction of Therapeutic Response
SIMPLE SUMMARY: Studies aimed at prediction of chemotherapeutic efficacy using patient-derived ex vivo cultures (referred to here as “functional testing”) have been increasing. The present review provides information on the various types of ex vivo cultures and endpoint assays that employ a range of...
Autores principales: | Tsukamoto, Yoshiyuki, Hirashita, Yuka, Shibata, Tomotaka, Fumoto, Shoichi, Kurogi, Shusaku, Nakada, Chisato, Kinoshita, Keisuke, Fuchino, Takafumi, Murakami, Kazunari, Inomata, Masafumi, Moriyama, Masatsugu, Hijiya, Naoki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452496/ https://www.ncbi.nlm.nih.gov/pubmed/37627132 http://dx.doi.org/10.3390/cancers15164104 |
Ejemplares similares
-
Association of immune‐related expression profile with sensitivity to chemotherapy in esophageal squamous cell carcinoma
por: Tsukamoto, Yoshiyuki, et al.
Publicado: (2023) -
Involvement of clusterin expression in the refractory response of pancreatic cancer cells to a MEK inhibitor
por: Amada, Kohei, et al.
Publicado: (2023) -
Reduced phosphorylation of ribosomal protein S6 is associated with sensitivity to MEK inhibition in gastric cancer cells
por: Hirashita, Yuka, et al.
Publicado: (2016) -
A 17-molecule set as a predictor of complete response to neoadjuvant chemotherapy with docetaxel, cisplatin, and 5-fluorouracil in esophageal cancer
por: Fujishima, Hajime, et al.
Publicado: (2017) -
S6 ribosomal protein phosphorylation is associated with malignancy of intraductal papillary mucinous neoplasm of the pancreas
por: Hirashita, Teijiro, et al.
Publicado: (2020)